CYCS and breast cancer: Table 4 shows the effects of testing triazole derivatives 8e and 8g as cytochrome C activators in the MCF-7 human breast cancer cell line. 8e and 8g resulted in around 11.90- and 12.76-fold higher levels of cytochrome C expression than untreated control cells.